G1 THERAPEUTICS, INC. Marketable Securities (Current)
G1 THERAPEUTICS, INC. had Marketable Securities (Current) of $45.66 million as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2024-08-08
- 2024-06-30: Marketable Securities, Current $45.66M.
- 2024-03-31: Marketable Securities, Current $45.30M.
- 2023-12-31: Marketable Securities, Current $49.94M.
- 2023-09-30: Marketable Securities, Current $41.73M.
| Period end | Marketable Securities, Current |
|---|---|
| 2024-06-30 | $45.66M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $45.30M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $49.94M 10-Q · filed 2024-08-08 |
| 2023-09-30 | $41.73M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $48.32M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $48.08M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $50.48M 10-K · filed 2024-02-28 |
| 2022-09-30 | $29.74M 10-Q · filed 2022-11-02 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 |